Form 8-K - Current report:
SEC Accession No. 0001213900-19-026622
Filing Date
2019-12-20
Accepted
2019-12-20 09:12:46
Documents
3
Period of Report
2019-12-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k122019_wizepharmainc.htm 8-K 31750
2 FORM OF PURCHASE AGREEMENT f8k122019ex10-1_wize.htm EX-10.1 75630
3 FORM OF WARRANT f8k122019ex10-2_wize.htm EX-10.2 99883
  Complete submission text file 0001213900-19-026622.txt   208605
Mailing Address 24 HANAGAR ST HOD HASHARON L3 4527713
Business Address 24 HANAGAR ST HOD HASHARON L3 4527713 972 472 260 0536
Wize Pharma, Inc. (Filer) CIK: 0001218683 (see all company filings)

EIN.: 880445167 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52545 | Film No.: 191297822
SIC: 2834 Pharmaceutical Preparations